Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
August 27, 2025
Quantitative myocardial perfusion cardiovascular magnetic resonance (CMR) is emerging as a game-changer in cardiovascular imaging for patients with known or suspected coronary artery disease (CAD), as well as those with ischemia without obstructive coronary arteries (INOCA), anomalous coronary origins, and Kawasaki disease. International guidelines now grant several Class 1 indications for stress perfusion CMR, underlining its excellent diagnostic accuracy and independent prognostic value—a hallmark for clinical confidence.
Traditionally, clinicians rely on visual interpretation of stress perfusion CMR images. The consensus highlights that quantitative perfusion CMR is at least as accurate for detecting significant obstructive CAD and is even more precise in estimating the total ischemic burden for CAD patients. This distinction provides deeper, more reproducible data for risk stratification and management.
Quantitative perfusion CMR stands out by uncovering pathophysiological mechanisms of myocardial ischemia, notably in microvascular dysfunction—a common culprit in INOCA. This capability brings clarity to ambiguous cases where angiograms appear normal but symptoms persist, guiding therapy and research into conditions often overlooked in routine practice.
A major advancement is that quantitative analysis of myocardial perfusion can be fully automated and user-independent, paving the way for broader implementation in clinical routines beyond specialist centers. The consensus aims to standardize acquisition and analysis methods, which is fundamental for reliability, validity, and multi-center research collaboration.
The statement emphasizes the following development goals:
The SCMR Expert Consensus Statement underscores the expanding value of quantitative myocardial perfusion CMR for clinical decision-making in coronary artery disease (CAD), ischemia with non-obstructive coronaries (INOCA), anomalous coronary origins, and Kawasaki disease. Stress perfusion CMR is now recognized in international guidelines with several Class 1 indications testament to its excellent diagnostic accuracy and independent prognostic power.